A long-term comparison of galantamine and donepezil in the treatment of Alzheimer’s disease Posted on June 8, 2016 by tsuperadmin -
NCT00236431 – A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00236574 – A Randomized Double Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment (MCI) Clinically at Risk for Development of Clinically Probable Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00253214 – Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer’s Disease: Safety and Efficacy of a Controlled-Release Formulation Posted on June 8, 2016 by tsuperadmin -
NCT00253188 – Efficacy, Tolerability and Safety of Galantamine in the Treatment of Alzheimer’s Disease Posted on June 8, 2016 by tsuperadmin -
NCT00261573 – The Safety and Efficacy of Galantamine in the Treatment of Vascular and Mixed Dementia Posted on June 8, 2016 by tsuperadmin -
NCT00034762 – Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer’s Disease Posted on March 31, 2016 by tsuperadmin -
Efficacy and safety of a flexible dose of risperidone versus placebo in the treatment of psychosis of Alzheimer’s disease. A double-blind, placebo-controlled, parallel-group study. Posted on March 31, 2016 by tsuperadmin -
Long Term Safety and Efficacy of Galantamine in the treatment of Alzheimer’s Disease Posted on February 11, 2015 by tsuperadmin -
Long Term Safety and Efficacy of Galantamine in the treatment of Alzheimer’s Disease Posted on February 11, 2015 by tsuperadmin -